SH2D1B and B-cell chronic lymphocytic leukemia: In line with our assumption, we found no EAT2 expression in the majority of CLL samples (69%) and no correlation with SLAMF receptor status in the few samples positive for EAT2 supporting our hypothesis (Fig. 4a).